Research map: Faster dementia progression was associated with use of potentially inappropriate medications

Back to the article

Papers in this map

  1. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia · Suzanne M Dyer · 2017 · 394 citations · Cited by this paper
  2. The Effect of the combination therapy of statin and dapagliflozin, a selective inhibitor of sodium_glucose Co-transporter type 2, in the treatment of Ischemic heart disease with heart failure: A randomized controlled trial · 2026 · Related
  3. Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community‐dwelling older patients acutely admitted to hospital? A N orwegian registry‐based study · Kjerstin Havnes · 2022 · 5 citations · Cited by this paper
  4. Acetaminophen exposure in an aging population and neurodegenerative outcomes · 2026 · Related
  5. Potentially inappropriate medications related to two-year progression of mild cognitive impairment and dementia · Hege Kersten · 2026 · 3 citations · Cited by this paper
  6. Population pharmacokinetics of unbound imipenem in critically ill patients: a comparison of five renal function estimators for PK/PD-guided dosing · 2026 · Related
  7. Examining the risk of neurotoxicity in patients who receive unadjusted doses of oral beta-lactams in renal insufficiency: a retrospective cohort study · 2026 · Related
  8. Secondary data analysis of Adverse Drug Reactions reported by healthcare professionals and patients: interventions to manage ADRs of ACE inhibitors and ARBs · 2026 · Related
  9. Detection of intravenous drug physicochemical incompatibilities in clinical practice: e-Harvis compared to reference tools · 2026 · Related
  10. Effects of renal impairment on the pharmacokinetics, safety, and tolerability of pudexacianinium (ASP5354) after IV administration: a mechanistic exploration · 2026 · Related
  11. Authors response to the comments by Muhammad Salman, Muhammad Hammad Chola and Muhammad Hasan on our paper “prescribing patterns of glucagon like peptide-1 receptor agonists in the Swedish capital region: a register-based cross-sectional study” · 2026 · Related
  12. Response to comment on “CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy” · 2026 · Related
  13. The role of Spanish clinical pharmacologists in economic evaluations of health technologies · 2026 · Related

Source: OpenAlex (CC0)